Source 1review2026MED
Toolkit/opsins
opsins
Also known as: light-sensitive microbial ion channels, light-sensitive proteins
Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Optogenetics has revolutionized the field of neuroscience by enabling precise control of neural activity through light-sensitive proteins known as opsins.
Usefulness & Problems
Why this is useful
Opsins are light-sensitive proteins used to control neural activity in optogenetic systems. The review discusses both excitatory and inhibitory opsins.; precise control of neural activity; activation of excitatory and inhibitory optogenetic responses; Opsins are the light-sensitive proteins used in optogenetics to control cell activity. In this review, they are the central payload class underlying retinal optogenetic therapy.; conferring light sensitivity to targeted cells; enabling optical control in retinal therapeutic constructs; Opsins are the light-responsive actuators used in cardiac optogenetics to modulate membrane potential and cellular function. In this review context they are used to control myocardial activity with light.; noninvasive optical modulation of membrane potential; cell-type selective control of cardiac cellular function; photoactivation of cardiac contractions; interrogation of myocardial cell networks; Opsins are the genetically encoded light-sensitive proteins used in optogenetic techniques. In the abstract, they are the enabling components that allow light-based control of neuronal activity, signaling, or gene expression.; serving as genetically encoded light-sensitive actuators; enabling modulation of neuronal activity; enabling modulation of intracellular signaling pathways; enabling modulation of gene expression; Opsins are light-sensitive microbial ion channels used to modulate excitable cells with light. In the review abstract, they are presented as the core actuators enabling cardiac optogenetics.; light-based modulation of excitable cells; non-invasive control with high spatial resolution; millisecond-timescale perturbation of cardiac electrophysiology
Source:
Opsins are light-sensitive proteins used to control neural activity in optogenetic systems. The review discusses both excitatory and inhibitory opsins.
Source:
precise control of neural activity
Source:
activation of excitatory and inhibitory optogenetic responses
Source:
Opsins are the light-sensitive proteins used in optogenetics to control cell activity. In this review, they are the central payload class underlying retinal optogenetic therapy.
Source:
conferring light sensitivity to targeted cells
Source:
enabling optical control in retinal therapeutic constructs
Source:
Opsins are the light-responsive actuators used in cardiac optogenetics to modulate membrane potential and cellular function. In this review context they are used to control myocardial activity with light.
Source:
noninvasive optical modulation of membrane potential
Source:
cell-type selective control of cardiac cellular function
Source:
photoactivation of cardiac contractions
Source:
interrogation of myocardial cell networks
Source:
Opsins are the genetically encoded light-sensitive proteins used in optogenetic techniques. In the abstract, they are the enabling components that allow light-based control of neuronal activity, signaling, or gene expression.
Source:
serving as genetically encoded light-sensitive actuators
Source:
enabling modulation of neuronal activity
Source:
enabling modulation of intracellular signaling pathways
Source:
enabling modulation of gene expression
Source:
Opsins are light-sensitive microbial ion channels used to modulate excitable cells with light. In the review abstract, they are presented as the core actuators enabling cardiac optogenetics.
Source:
light-based modulation of excitable cells
Source:
non-invasive control with high spatial resolution
Source:
millisecond-timescale perturbation of cardiac electrophysiology
Problem solved
They provide precise control of neural circuits for neuroscience and potential therapy.; enables light-based control of neural circuits; They provide the photosensitive function that can substitute for lost native light responsiveness in degenerating retina.; provide the light-responsive component needed for optogenetic control; They solve the problem of noninvasive, cell-type selective perturbation of cardiac electrical activity and function. The review also links them to photoactivation of contractions and arrhythmia-control studies.; enables light-based control of excitable cardiac cells; supports selective perturbation of myocardial cell types; They solve the need for a genetically encoded interface between light delivery and cellular control.; provide the light-sensitive protein component required for optogenetic control; They allow non-invasive, spatially precise, millisecond-scale control of cardiac and other excitable cells. This supports mechanistic studies of electrophysiology and arrhythmias.; enables optical control of genetically modified excitable cells in the heart
Source:
They provide precise control of neural circuits for neuroscience and potential therapy.
Source:
enables light-based control of neural circuits
Source:
They provide the photosensitive function that can substitute for lost native light responsiveness in degenerating retina.
Source:
provide the light-responsive component needed for optogenetic control
Source:
They solve the problem of noninvasive, cell-type selective perturbation of cardiac electrical activity and function. The review also links them to photoactivation of contractions and arrhythmia-control studies.
Source:
enables light-based control of excitable cardiac cells
Source:
supports selective perturbation of myocardial cell types
Source:
They solve the need for a genetically encoded interface between light delivery and cellular control.
Source:
provide the light-sensitive protein component required for optogenetic control
Source:
They allow non-invasive, spatially precise, millisecond-scale control of cardiac and other excitable cells. This supports mechanistic studies of electrophysiology and arrhythmias.
Source:
enables optical control of genetically modified excitable cells in the heart
Problem links
enables light-based control of excitable cardiac cells
LiteratureThey solve the problem of noninvasive, cell-type selective perturbation of cardiac electrical activity and function. The review also links them to photoactivation of contractions and arrhythmia-control studies.
Source:
They solve the problem of noninvasive, cell-type selective perturbation of cardiac electrical activity and function. The review also links them to photoactivation of contractions and arrhythmia-control studies.
enables light-based control of neural circuits
LiteratureThey provide precise control of neural circuits for neuroscience and potential therapy.
Source:
They provide precise control of neural circuits for neuroscience and potential therapy.
enables optical control of genetically modified excitable cells in the heart
LiteratureThey allow non-invasive, spatially precise, millisecond-scale control of cardiac and other excitable cells. This supports mechanistic studies of electrophysiology and arrhythmias.
Source:
They allow non-invasive, spatially precise, millisecond-scale control of cardiac and other excitable cells. This supports mechanistic studies of electrophysiology and arrhythmias.
provide the light-responsive component needed for optogenetic control
LiteratureThey provide the photosensitive function that can substitute for lost native light responsiveness in degenerating retina.
Source:
They provide the photosensitive function that can substitute for lost native light responsiveness in degenerating retina.
provide the light-sensitive protein component required for optogenetic control
LiteratureThey solve the need for a genetically encoded interface between light delivery and cellular control.
Source:
They solve the need for a genetically encoded interface between light delivery and cellular control.
supports selective perturbation of myocardial cell types
LiteratureThey solve the problem of noninvasive, cell-type selective perturbation of cardiac electrical activity and function. The review also links them to photoactivation of contractions and arrhythmia-control studies.
Source:
They solve the problem of noninvasive, cell-type selective perturbation of cardiac electrical activity and function. The review also links them to photoactivation of contractions and arrhythmia-control studies.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Component: A low-level protein part used inside a larger architecture that realizes a mechanism.
Mechanisms
light-gated ion conductanceoptical control of cellular activity via genetically encoded photosensitivityTranslation ControlTechniques
Directed EvolutionTarget processes
signalingtranslationInput: Light
Implementation Constraints
cofactor dependency: requires exogenous cofactorencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenimplementation constraint: spectral hardware requirementoperating role: regulatorswitch architecture: single chain
Opsins must be delivered and expressed in target cells, typically through recombinant viral vectors according to the abstract.; requires delivery to target cells; requires appropriate targeting strategy for expression; Opsins require gene delivery into target cells and an illumination regime that can activate them. The abstract also implies the need for cell-targeting strategies.; must be delivered to genetically targeted cells; require compatible light exposure for activation; Use requires opsin expression in target myocardial cell types or model organisms and a light-delivery setup. The abstract supports genetic targeting as a prerequisite but does not specify delivery vectors or hardware details.; genetic introduction or model-organism expression of opsins is required; light delivery is required for actuation; Their use requires genetic introduction and selective expression in the cells of interest.; must be selectively expressed; are exogenous light-sensitive proteins; Use requires genetic modification of excitable cells to express opsins and a light-delivery setup. The abstract also implies application in intact organs and cardiac preparations.; target cells must be genetically modified to express light-sensitive microbial ion channels; requires light delivery
The abstract indicates that optogenetic tools still face delivery and targeting limitations that require additional strategies.; delivery and targeting limitations are discussed in the review; The abstract does not establish that opsin choice alone resolves delivery, targeting, or translation challenges.; the abstract does not specify which opsin classes or their comparative tradeoffs; The abstract does not show that opsins alone solve delivery, expression, or translational deployment challenges. It also does not specify performance tradeoffs among different opsin variants.; requires targeted expression of opsins in myocardial cell types; The abstract does not specify which opsin variants are optimal for excitation, inhibition, expression, or epilepsy-specific deployment.; The abstract does not specify which opsin variants best solve particular cardiac use cases or how expression is achieved. It also does not establish detailed translational performance limits.; requires genetic modification to express opsins
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2review2025Biomolecules
Source 3review2018Frontiers in Cellular Neuroscience
Source 4review2016Biochemical and Biophysical Research Communications
Ranked Claims
Optogenetics enables precise control of neural activity through light-sensitive opsins.
Adeno-associated viruses are presented as a promising clinical delivery approach for opsins to target cells and can improve flexibility and accuracy of opsin delivery when combined with cell-specific promoters and serotype choice.
Bioluminescent optogenetics combines optogenetic principles with bioluminescent proteins to visualize and manipulate neural activity in real time and can support efficient, less invasive monitoring of neuronal activity.
Cell-specific promoters are essential for precise and efficient optogenetic stimulation because they restrict opsin expression to selected target cells.
Clinical translation of optogenetic therapy for AMD faces challenges and requires further development.
AAVs serve as delivery vectors in retinal disease models via intravitreal or subretinal injections.
In retinal disease models, adeno-associated viruses (AAVs) serve as delivery vectors via intravitreal or subretinal injections.
In retinal disease models, AAVs serve as delivery vectors for optogenetic approaches via intravitreal or subretinal injection.
The paper discusses optogenetic tools, delivery methods, challenges, future directions, preclinical AMD models, and clinical translation potential for AMD-related vision loss.
This review explores the principles of optogenetics, its application in preclinical AMD models, and the potential for clinical translation of this approach. We discuss the various optogenetic tools, delivery methods, and the challenges and future directions in harnessing this technology to combat AMD-related vision loss.
Optogenetics uses genetically encoded light-sensitive proteins such as opsins to enable control of neuronal activity, intracellular signaling pathways, or gene expression.
Selective expression of exogenous light-sensitive proteins enables spatial, directional, temporal, and cell-type specificity in optogenetic modulation.
Optogenetics enables non-invasive, high-spatial-resolution, millisecond-timescale modulation of genetically modified excitable cells via light-sensitive microbial ion channels.
The brightest side of this technology is the use of light to modulate non-invasively, with high spatial resolution and millisecond time scale, excitable cells genetically modified to express light-sensitive microbial ion channels (opsins).
Approval Evidence
5 sources10 linked approval claimsfirst-pass slug opsins
Optogenetics has revolutionized the field of neuroscience by enabling precise control of neural activity through light-sensitive proteins known as opsins.
Source:
Optogenetics, a revolutionary technique utilizing light-sensitive proteins (opsins) to control the activity of genetically targeted cells...
Source:
Rhodopsin-based optogenetics has later been introduced in experimental cardiology studies... The exploitation of cell-selectivity of optogenetics, and the generation of model organisms with myocardial cell type targeted expression of opsins...
Source:
Optogenetics is a powerful and rapidly expanding set of techniques that use genetically encoded light sensitive proteins such as opsins.
Source:
The brightest side of this technology is the use of light to modulate non-invasively, with high spatial resolution and millisecond time scale, excitable cells genetically modified to express light-sensitive microbial ion channels (opsins).
Source:
capability summarysupports
Optogenetics enables precise control of neural activity through light-sensitive opsins.
Source:
delivery strategy summarysupports
Adeno-associated viruses are presented as a promising clinical delivery approach for opsins to target cells and can improve flexibility and accuracy of opsin delivery when combined with cell-specific promoters and serotype choice.
Source:
targeting summarysupports
Cell-specific promoters are essential for precise and efficient optogenetic stimulation because they restrict opsin expression to selected target cells.
Source:
challenge statementsupports
Clinical translation of optogenetic therapy for AMD faces challenges and requires further development.
Source:
application summarysupports
Rhodopsin-based optogenetics has been used in experimental cardiology to photoactivate cardiac contractions and to identify effective sites, timing, and location for defibrillating impulses that interrupt cardiac arrhythmias.
Rhodopsin-based optogenetics has later been introduced in experimental cardiology studies and used as a tool to photoactivate cardiac contractions or to identify the sites, timing, and location most effective for defibrillating impulses to interrupt cardiac arrhythmias.
Source:
biological insight summarysupports
Cell-selective optogenetics and myocardial cell type targeted opsin expression in model organisms have begun to reveal novel and sometimes unexpected aspects of myocardial biology.
The exploitation of cell-selectivity of optogenetics, and the generation of model organisms with myocardial cell type targeted expression of opsins has started to yield novel and sometimes unexpected notions on myocardial biology.
Source:
review scope summarysupports
Optogenetics provides noninvasive, cell-type selective modulation of membrane potential and cellular function in vitro and in vivo.
The discovery of optogenetics has revolutionized research in neuroscience by providing the tools for noninvasive, cell-type selective modulation of membrane potential and cellular function in vitro and in vivo.
Source:
capability summarysupports
Optogenetics uses genetically encoded light-sensitive proteins such as opsins to enable control of neuronal activity, intracellular signaling pathways, or gene expression.
Source:
specificity summarysupports
Selective expression of exogenous light-sensitive proteins enables spatial, directional, temporal, and cell-type specificity in optogenetic modulation.
Source:
review scope summarysupports
Optogenetics enables non-invasive, high-spatial-resolution, millisecond-timescale modulation of genetically modified excitable cells via light-sensitive microbial ion channels.
The brightest side of this technology is the use of light to modulate non-invasively, with high spatial resolution and millisecond time scale, excitable cells genetically modified to express light-sensitive microbial ion channels (opsins).
Source:
Comparisons
Source-stated alternatives
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.; The abstract does not name specific alternative payload classes beyond opsins.; The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.; The abstract only states 'light sensitive proteins such as opsins' and does not name alternative actuator classes.; The abstract contrasts optogenetics with prior non-optical approaches only implicitly and does not name specific alternatives. It frames optogenetics as a new way to interrogate cardiovascular physiology.
Source:
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.
Source:
The abstract does not name specific alternative payload classes beyond opsins.
Source:
The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.
Source:
The abstract only states 'light sensitive proteins such as opsins' and does not name alternative actuator classes.
Source:
The abstract contrasts optogenetics with prior non-optical approaches only implicitly and does not name specific alternatives. It frames optogenetics as a new way to interrogate cardiovascular physiology.
Source-backed strengths
supports precise control of neural activity; serve as the core light-sensitive component of optogenetic systems; noninvasive modulation; cell-type selective control; usable in vitro and in vivo; genetically encoded; support spatial, directional, temporal, and cell-type specificity when selectively expressed; non-invasive modulation; high spatial resolution; millisecond time scale
Source:
supports precise control of neural activity
Source:
serve as the core light-sensitive component of optogenetic systems
Source:
noninvasive modulation
Source:
cell-type selective control
Source:
usable in vitro and in vivo
Source:
genetically encoded
Source:
support spatial, directional, temporal, and cell-type specificity when selectively expressed
Source:
non-invasive modulation
Source:
high spatial resolution
Source:
millisecond time scale
Compared with optogenetic
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.; The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.
Shared frame: source-stated alternative in extracted literature
Strengths here: supports precise control of neural activity; serve as the core light-sensitive component of optogenetic systems; noninvasive modulation.
Relative tradeoffs: delivery and targeting limitations are discussed in the review; the abstract does not specify which opsin classes or their comparative tradeoffs; requires targeted expression of opsins in myocardial cell types.
Source:
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.
Source:
The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.
Compared with optogenetic functional interrogation
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.; The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.; The abstract contrasts optogenetics with prior non-optical approaches only implicitly and does not name specific alternatives. It frames optogenetics as a new way to interrogate cardiovascular physiology.
Shared frame: source-stated alternative in extracted literature
Strengths here: supports precise control of neural activity; serve as the core light-sensitive component of optogenetic systems; noninvasive modulation.
Relative tradeoffs: delivery and targeting limitations are discussed in the review; the abstract does not specify which opsin classes or their comparative tradeoffs; requires targeted expression of opsins in myocardial cell types.
Source:
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.
Source:
The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.
Source:
The abstract contrasts optogenetics with prior non-optical approaches only implicitly and does not name specific alternatives. It frames optogenetics as a new way to interrogate cardiovascular physiology.
Compared with optogenetic membrane potential perturbation
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.; The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.; The abstract contrasts optogenetics with prior non-optical approaches only implicitly and does not name specific alternatives. It frames optogenetics as a new way to interrogate cardiovascular physiology.
Shared frame: source-stated alternative in extracted literature
Strengths here: supports precise control of neural activity; serve as the core light-sensitive component of optogenetic systems; noninvasive modulation.
Relative tradeoffs: delivery and targeting limitations are discussed in the review; the abstract does not specify which opsin classes or their comparative tradeoffs; requires targeted expression of opsins in myocardial cell types.
Source:
The abstract contrasts standard optogenetic use with modified opsins and bioluminescent optogenetics as related approaches.
Source:
The abstract contrasts optogenetics with prior neuroscience and cardiology methods only implicitly and does not name direct non-optogenetic alternatives. Within optogenetics, it refers broadly to rhodopsin-based tools rather than specific substitutes.
Source:
The abstract contrasts optogenetics with prior non-optical approaches only implicitly and does not name specific alternatives. It frames optogenetics as a new way to interrogate cardiovascular physiology.
Ranked Citations
- 1.
- 2.
- 3.
- 4.